Demethylation drugs that inhibit DNMT3B expression reduce the degree of methylation of tumor suppressor genes, thus restoring the expression of these genes and thereby significantly decreasing the proliferation and invasion ability of tumor cells14. The gene discussed is DNMT3B; the disease is neoplasm.